Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma

NCT04113226 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy
Diffuse Large B-Cell Lymphoma (DLBCL), Nos
Elderly

Interventions

DRUG: Rituximab
DRUG: Lenalidomide 20 MG
OTHER: Comprehensive Geriatric Assessment (CGA)
OTHER: Activities of daily living (ADL) scale

Sponsor

Centre Hospitalier Universitaire, Amiens

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]